• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SLN

SLN

Silence Therapeutics plc

NASDAQHealthcareBiotechnologyGB

USD6.41

+0.04 (+0.63%)

Rating:C+

Company Profile

CEO

Iain Gladstone Ross

IPO Date

2020-09-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

GB

Market Metrics

Open

$6.36

Prev. Close

$6.37

Day Low

$6.34

Day High

$6.56

52W Low

$4.19

52W High

$8.40

Market Cap

$0.30B

Volume

0.12M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.9%

Avg Negative

1.7%

Avg Neutral

48.4%

News Feed

Silence Therapeutics' siRNA Candidate Reduces Plasma Iron Levels, Early-Stage Study Shows

Benzinga·5/19/2021·↑ positive

Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers

GlobeNewsWire·5/19/2021·↑ positive

Silence Therapeutics shares positive data from phase I study of its lead asset

Proactive Investors
·5/19/2021
·↑ positive

Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Conference

GlobeNewsWire·5/12/2021·↑ positive

Silence Therapeutics says phase I trial of lead asset is now underway

Proactive Investors·4/29/2021·↑ positive

Silence Therapeutics receives further US$2mln under Mallinckrodt deal

Proactive Investors·4/28/2021·↑ positive

Silence Therapeutics Announces Publication in Cardiovascular Research Highlighting the Emerging Potential of RNA Therapeutics in Preventing Lipoprotein(a)-Mediated Cardiovascular Disease

GlobeNewsWire·4/15/2021·↑ positive

Silence Therapeutics assess the use of RNAi in heart disease

Proactive Investors·4/15/2021·↑ positive

Silence Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/7/2021·↑ positive

Silence Therapeutics plc's (SLN) CEO Mark Rothera on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/30/2021·↓ negative